Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-12-11

Clinical Trial Update: Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating an antibiotic–steroid ophthalmic combination vs its individual components for ocular inflammation and infection was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antibiotic–steroid ophthalmic combination

Snippet

Sponsor: Adapt Produtos Oftalmológicos Ltda. | Conditions: Ocular Inflammation, Infection Associated Blepharitis | Phase 3 | Status: WITHDRAWN